Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT07556497

Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes

Led by Weill Cornell Medical College in Qatar · Updated on 2026-04-29

90

Participants Needed

1

Research Sites

319 weeks

Total Duration

On this page

Sponsors

W

Weill Cornell Medical College in Qatar

Lead Sponsor

H

Hamad Medical Corporation

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to isolate endothelial progenitor cells (EPCs) from participants with type 2 diabetes (T2D) and cardiovascular complications and to comprehensively characterize EPC dysfunction. Specifically, the study will evaluate maladaptive angiocrine signaling, calcium signaling pathways, and the role of inflammation in EPC function and the progression of atherosclerosis during T2D development. A sub-study will assess EPC functionality by examining endothelial nitric oxide synthase (eNOS) expression and activity, as well as the effectiveness of in vitro eNOS gene enhancement.

CONDITIONS

Official Title

Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of type 2 diabetes (T2D)
  • Male or female
  • Age older than 18 years
  • Willing to participate and provide written consent
  • Agree to provide peripheral blood and urine samples for the study
Not Eligible

You will not qualify if you...

  • Does not meet inclusion criteria
  • Type 1 diabetes, MODY diabetes, or other forms of diabetes
  • Active infection, inflammation, cancer, or acute illness (except cardiovascular complications related to diabetes)
  • Chronic inflammation such as autoimmune diseases or infections like HIV or chronic hepatitis
  • History of malignancy within the past 5 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hamad Medical Corporation

Doha, Qatar

Actively Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Role of Endothelial Progenitor Cells Dysregulation and Inflammation in the Pathophysiology of Cardiovascular Complications of Type 2 Diabetes | DecenTrialz